{
    "Trade/Device Name(s)": [
        "BreathID\u00ae Hp Lab System",
        "IDkit Hp\u2122 Two"
    ],
    "Submitter Information": "Exalenz Bioscience Ltd.",
    "510(k) Number": "K162150",
    "Predicate Device Reference 510(k) Number(s)": [
        "K130524"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "MSQ",
        "JJQ"
    ],
    "Summary Letter Date": "October 31, 2016",
    "Summary Letter Received Date": "August 2, 2016",
    "Submission Date": "July 28, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.3110"
    ],
    "Regulation Name(s)": [
        "Campylobacter fetus serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Helicobacter pylori",
        "13CO2",
        "12CO2"
    ],
    "Specimen Type(s)": [
        "Exhaled breath"
    ],
    "Specimen Container(s)": [
        "Breath collection bag"
    ],
    "Instrument(s)/Platform(s)": [
        "BreathID\u00ae Hp Lab device",
        "Auto Sampler",
        "Lab Application"
    ],
    "Method(s)/Technology(ies)": [
        "Molecular Correlation Spectroscopy (MCS)",
        "Optical absorption spectroscopy"
    ],
    "Methodologies": [
        "Detection of 13CO2/12CO2 ratio in breath",
        "Infrared spectrometry"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Kit",
        "Accessory",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Exalenz BreathID Hp Lab System for non-invasive breath testing to aid diagnosis and monitoring of Helicobacter pylori infection using 13C-urea substrate.",
    "Indications for Use Summary": "Aid in initial diagnosis and post-treatment monitoring of H. pylori infection in adult patients by non-invasively measuring breath 13CO2/12CO2 ratio indicative of urease activity.",
    "fda_folder": "Microbiology"
}